Total Payments
$9,758
2024 Payments
$2,449
Companies
23
Transactions
540
Medicare Patients
2,523
Medicare Billing
$134,098
Payment Breakdown by Category
Food & Beverage$9,428 (96.6%)
Education$330.26 (3.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,428 | 534 | 96.6% |
| Education | $330.26 | 6 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,117 | 128 | $0 (2024) |
| GENZYME CORPORATION | $1,102 | 49 | $0 (2024) |
| Janssen Biotech, Inc. | $751.63 | 40 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $734.44 | 34 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $720.08 | 31 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $684.53 | 34 | $0 (2024) |
| LEO Pharma Inc. | $634.99 | 46 | $0 (2024) |
| PFIZER INC. | $541.23 | 35 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $469.83 | 23 | $0 (2024) |
| Incyte Corporation | $465.10 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,449 | 125 | ABBVIE INC. ($441.00) |
| 2023 | $2,485 | 127 | ABBVIE INC. ($547.96) |
| 2022 | $2,829 | 158 | ABBVIE INC. ($627.14) |
| 2021 | $1,996 | 130 | AbbVie Inc. ($500.96) |
All Payment Transactions
540 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.28 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/03/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.96 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: Immunology | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.46 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.47 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.32 | General |
| Category: Immunology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.92 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $31.95 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.03 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.79 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $35.35 | General |
| Category: Inflammation & Immunology | ||||||
| 11/06/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: DERMATOLOGY | ||||||
| 11/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.19 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: Immunology | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, ZEPBOUND | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 754 | 1,686 | $106,181 | $45,290 |
| 2022 | 13 | 647 | 1,477 | $87,426 | $34,671 |
| 2021 | 13 | 615 | 1,232 | $79,135 | $32,774 |
| 2020 | 13 | 507 | 1,036 | $59,226 | $21,363 |
Total Patients
2,523
Total Services
5,431
Medicare Billing
$134,098
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 171 | $15,390 | $8,595 | 55.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 78 | 96 | $12,000 | $6,044 | 50.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 69 | $8,832 | $5,209 | 59.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 73 | 130 | $16,900 | $5,098 | 30.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 71 | 87 | $11,745 | $4,562 | 38.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 83 | 124 | $11,160 | $4,089 | 36.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 50 | 50 | $5,750 | $3,219 | 56.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $3,960 | $2,348 | 59.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 22 | $4,400 | $2,239 | 50.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 74 | 530 | $10,600 | $2,120 | 20.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 17 | 20 | $1,500 | $641.38 | 42.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 22 | $1,430 | $468.91 | 32.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 39 | 55 | $1,650 | $433.92 | 26.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 37 | 288 | $864.00 | $223.52 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 97 | 144 | $12,960 | $6,723 | 51.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 57 | 70 | $8,750 | $4,687 | 53.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 73 | 113 | $14,690 | $4,603 | 31.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 73 | 82 | $11,070 | $4,528 | 40.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 72 | 100 | $9,000 | $3,215 | 35.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 47 | 47 | $5,405 | $2,883 | 53.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 54 | 68 | $4,420 | $2,161 | 48.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 12 | 19 | $6,555 | $1,757 | 26.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 64 | 446 | $8,920 | $1,681 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 14 | $1,792 | $1,083 | 60.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 19 | 19 | $1,520 | $783.47 | 51.5% |
About James Williams, PA-C
James Williams, PA-C is a Physician Assistant healthcare provider based in Thomasville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2018. The National Provider Identifier (NPI) number assigned to this provider is 1104391556.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, James Williams, PA-C has received a total of $9,758 in payments from pharmaceutical and medical device companies, with $2,449 received in 2024. These payments were reported across 540 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($9,428).
As a Medicare-enrolled provider, Williams has provided services to 2,523 Medicare beneficiaries, totaling 5,431 services with total Medicare billing of $134,098. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Thomasville, NC
- Active Since 10/11/2018
- Last Updated 10/11/2018
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1104391556
Products in Payments
- DUPIXENT (Biological) $1,815
- SKYRIZI (Biological) $1,061
- RINVOQ (Biological) $725.00
- TREMFYA (Drug) $626.00
- ADBRY (Biological) $574.44
- EUCRISA (Drug) $475.34
- Sotyktu (Drug) $469.83
- OPZELURA (Drug) $447.45
- Otezla (Drug) $355.20
- TALTZ (Drug) $354.21
- COSENTYX (Biological) $317.32
- HUMIRA (Biological) $301.50
- ILUMYA (Biological) $240.68
- VTAMA (Drug) $207.89
- COSENTYX (Drug) $206.77
- Absorica LD (Drug) $149.69
- REMICADE (Biological) $125.63
- Cimzia (Drug) $104.17
- Ilumya (Biological) $81.14
- Bimzelx (Biological) $76.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Thomasville
Marisa Faircloth, Pa-C, PA-C
Physician Assistant — Payments: $93,071
Physician Assistant $93,071
Fran Webb
Physician Assistant — Payments: $7,134
Physician Assistant $7,134
Amanda Coleman, Pa-C, PA-C
Physician Assistant — Payments: $4,846
Physician Assistant $4,846
William Brazil, Pa, PA
Physician Assistant — Payments: $3,746
Physician Assistant $3,746
Mr. Stanley Allen, Pac, PAC
Physician Assistant — Payments: $3,246
Physician Assistant $3,246
Brooklyn Green, Pa-C, PA-C
Physician Assistant — Payments: $2,594
Physician Assistant $2,594